Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology

被引:117
作者
Gustafsson, T
Kraus, WE
机构
[1] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Med Lab Sci & Technol, S-14186 Huddinge, Sweden
[3] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Cell Biol, Div Cardiol, Durham, NC 27710 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2001年 / 6卷
关键词
angiogenesis; angiogenic factors; exercise; skeletal muscle; review;
D O I
10.2741/gustafss
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis is the process of formation of new blood vessels; it is generally a rare occurrence in the adult, although it is a common adaptive response to exercise training in skeletal muscle. Current thinking is that angiogenesis is mediated by diffusible angiogenic factors and that the angiogenic activity is regulated through the balance between stimulatory and inhibitory factors. Recent studies have shown that up-regulation of angiogenic factors occurs in response to increased muscle activity in skeletal muscle. The major putative angiogenic factor, vascular endothelial growth factor (VEGF), seems to increase to a greater extent and more consistently than other measured angiogenic factors, such as fibroblast growth factor-2 (FGF-2) and transforming growth factor-beta (1) (TGF-beta (1)). While the regulating mechanisms in this response are not clear, present data indicate reduced oxygen tension and/or related metabolic alterations in the skeletal muscle as possible stimuli. Data on other angiogenic growth factors are limited, but an increase in endothelial cell-stimulating angiogenic growth factor (ESAF) has been observed in response to increased blood flow and muscle stretching. Therefore, different exercise associated stimuli may all contribute to exercise-induced angiogenesis in skeletal muscle, but possibly through differing angiogenic factors and mechanisms. Understanding these processes is important for the elucidation of mechanisms mediating exercise responsiveness in skeletal muscle, but also for the potential that such understanding might bring to the treatment and prevention of human diseases such as intermittent claudication.
引用
收藏
页码:D75 / D89
页数:15
相关论文
共 163 条
[41]   DOMINANT-NEGATIVE AND TARGETED NULL MUTATIONS IN THE ENDOTHELIAL RECEPTOR TYROSINE KINASE, TEK, REVEAL A CRITICAL ROLE IN VASCULOGENESIS OF THE EMBRYO [J].
DUMONT, DJ ;
GRADWOHL, G ;
FONG, GH ;
PURI, MC ;
GERTSENSTEIN, M ;
AUERBACH, A ;
BREITMAN, ML .
GENES & DEVELOPMENT, 1994, 8 (16) :1897-1909
[42]   Capillary density of skeletal muscle - A contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations [J].
Duscha, BD ;
Kraus, WE ;
Keteyian, SJ ;
Sullivan, MJ ;
Green, HJ ;
Schachat, FH ;
Pippen, AM ;
Brawner, CA ;
Blank, JM ;
Annex, BH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) :1956-1963
[43]   Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle [J].
Egginton, S ;
Hudlická, O ;
Brown, MD ;
Walter, H ;
Weiss, JB ;
Bate, A .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (06) :2025-2032
[44]   The role of αv integrins during angiogenesis:: insights into potential mechanisms of action and clinical development [J].
Eliceiri, BP ;
Cheresh, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1227-1230
[45]   Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia [J].
Enholm, B ;
Paavonen, K ;
Ristimaki, A ;
Kumar, V ;
Gunji, Y ;
Klefstrom, J ;
Kivinen, L ;
Laiho, M ;
Olofsson, B ;
Joukov, V ;
Eriksson, U ;
Alitalo, K .
ONCOGENE, 1997, 14 (20) :2475-2483
[46]   INFLUENCE OF A REHABILITATION SPORTS PROGRAM ON THE FIBRINOLYTIC-ACTIVITY OF PATIENTS AFTER MYOCARDIAL-INFARCTION [J].
ESTELLES, A ;
AZNAR, J ;
TORMO, G ;
SAPENA, P ;
TORMO, V ;
ESPANA, F .
THROMBOSIS RESEARCH, 1989, 55 (02) :203-212
[47]  
Fernig David G., 1994, Progress in Growth Factor Research, V5, P353, DOI 10.1016/0955-2235(94)00007-8
[48]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[49]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[50]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931